Valerian Root.

Valerian's valerenic acid and passionflower both increase signaling at GABA-A receptors, the brain's main calming system, so together they support the body's evening wind-down through one shared pathway. Their calming effects add together, which is the point of a nighttime formula but means drowsiness is stronger than with either alone.

Melatonin signals the timing of the normal sleep-wake cycle while valerian supports the GABA-driven calming that settles the body before sleep, so the pair covers two different parts of winding down rather than doubling up on one. Both can promote drowsiness, so evening alertness may drop more than with either alone.

L-theanine raises calming alpha brain-wave activity and gently supports GABA tone, working alongside valerian's direct action on GABA-A receptors to support a relaxed, settled state. It is a common evening pairing whose calming effects add together.

Apigenin from chamomile binds the benzodiazepine site of the GABA-A receptor, while valerenic acid acts at the beta subunit of the same receptor. Two distinct sites on one receptor make the effect additive.

Apigenin is the chamomile flavone that occupies the benzodiazepine site, a different binding pocket from the one valerenic acid uses. Isolated apigenin gives the same additive receptor effect as the whole herb.

Magnesium blocks the NMDA channel pore and acts as a positive modulator at GABA-A, and the glycine carrier is itself an inhibitory neurotransmitter. Valerian works only on the GABA side, so the excitatory brake is added rather than duplicated.

Magnesium dampens NMDA-mediated excitation and modulates GABA-A from a site valerenic acid does not use. The two lower excitability by separate routes.

Valerian raises GABA availability and changes receptor responsiveness, while supplemental GABA acts largely on peripheral receptors and the enteric nervous system. Formulators pair them to cover both sides of the same system.

Glycine acts on its own strychnine-sensitive inhibitory receptor and lowers core body temperature, a signal tied to sleep onset. Neither mechanism overlaps with GABA-A modulation.

5-HTP is converted to serotonin and onward to melatonin, setting the timing signal for sleep. Valerian acts on inhibitory tone rather than timing, so the two address different parts of sleep onset.

Tryptophan is the dietary precursor that feeds serotonin and then melatonin synthesis. It supplies the circadian arm that valerian does not touch.

Ashwagandha moderates evening cortisol, an upstream driver of a restless mind, while valerian acts directly on inhibitory receptor tone. The two address different links in the same chain.

Honokiol and magnolol are positive allosteric modulators at GABA-A acting at a site distinct from valerenic acid. Their effects on inhibitory tone add together.

Honokiol potentiates GABA-A currents at a site separate from the one valerenic acid occupies. The isolated compound behaves like the whole magnolia bark in this pairing.

Kavalactones modulate GABA-A and block voltage-gated sodium channels, so central depressant effects stack with valerenic acid rather than sitting alongside it. Total sedative load should be judged across both.

Taurine is a weak agonist at both GABA-A and glycine receptors and helps stabilise membrane excitability. It adds inhibitory tone through channels valerian does not act on.

Valerian and hops have been formulated together for well over a century and most of the clinical work on either herb in Europe used the fixed combination rather than valerian alone. Both are described as acting on GABAergic and adenosine signalling, so the pairing is coherent as well as traditional. Where a study used the combination, the result belongs to the combination and cannot be split between the two.

Lavender preparations are widely combined with valerian in evening formulas, and lavender's linalool has its own laboratory work on calcium channel and GABAergic activity. The pairing is a formulation convention with mechanistic plausibility behind it. No trial isolates what each herb contributes inside the blend.

Glutamate decarboxylase, the enzyme that makes GABA from glutamate, requires pyridoxal 5-phosphate as its cofactor. Valerenic acid acts at the receptor end of that system rather than on synthesis, so the two touch GABA signalling from opposite ends. The cofactor relationship is textbook biochemistry; it does not show that adding B6 raises GABA in someone whose B6 status is already adequate.

Caffeine is an adenosine receptor antagonist and promotes wakefulness, which runs against what a valerian preparation is taken for. Valerian constituents have been described as binding adenosine A1 receptors in laboratory work, so the two may meet at the same receptor as well as at the level of behaviour. Taken in the same evening they work against each other.

St John's wort induces CYP3A4 and P-glycoprotein, which changes the clearance of many co-administered compounds. The two herbs appear together in older combination mood and sleep products despite that. Anyone taking prescription medicine alongside such a combination should raise it with their prescriber before starting.

Lion's mane appears in evening stacks alongside valerian in the retail market, but the two act through unrelated pathways and no combination study exists. This is a shelf pairing rather than a pharmacological one. It is listed so a formulator sees it flagged as convention rather than mechanism.

Valepotriates in valerian are epoxide-containing esters that break down with heat, acid and time. Reducing agents and strong acids in the same capsule can accelerate that degradation. The point is stability of the botanical rather than any shared biology, and it is worth checking in a finished product rather than assuming.